Clinical Experience with Recombinant Activated Factor VII in a Surgical Patient with Coagulation Factor VII Deficiency: A case report / 대한마취과학회지
Korean Journal of Anesthesiology
; : 609-611, 2007.
Article
em Ko
| WPRIM
| ID: wpr-223093
Biblioteca responsável:
WPRO
ABSTRACT
A 33-yr old female patient with coagulation factor VII deficiency was scheduled for laparoscopic oophorectomy under the diagnosis of ovarian teratoma. Plasma concentration of factor VII of this patient was 9 IU/dl (normal range; 60-140 IU/dl) and the prothrombin time INR (International Normalization Ratio) was 1.79 (normal range; 0.8-1.2) on the day before the operation. Total 1,200microgram (30microgram/kg) of recombinant activated factor VII (rFVIIa) was administered just before the start of the laparoscopic procedure, which was accomplished safely without severe hemorrhage or other complications. Postoperative course was uneventful. In addition, this article provides the clinical implication of rFVIIa in terms of hemostasis management in hemophiliacs and surgical patients.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Plasma
/
Tempo de Protrombina
/
Teratoma
/
Coagulação Sanguínea
/
Fatores de Coagulação Sanguínea
/
Fator VII
/
Ovariectomia
/
Fator VIIa
/
Coeficiente Internacional Normatizado
/
Diagnóstico
Tipo de estudo:
Diagnostic_studies
Limite:
Female
/
Humans
Idioma:
Ko
Revista:
Korean Journal of Anesthesiology
Ano de publicação:
2007
Tipo de documento:
Article